|
|
| | 5,6-Diamino-1,3-dimethyluracil hydrate Basic information |
| Product Name: | 5,6-Diamino-1,3-dimethyluracil hydrate | | Synonyms: | 2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-1,3-dimethyl-;5,6-DiaMino-1,3-diMethyluracil hydrate technical grade;5,6-Diamino-1,3-dimethylurea;2,4(1H,3H);5,6-DIAMINO-1,3-DIMETHYLURACIL HYDRATE;3h)-pyrimidinedione,5,6-diamino-1,3-dimethyl-4(1h;5,6-Diamino-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione;Uracil, 5,6-diamino-1,3-dimethyl- | | CAS: | 5440-00-6 | | MF: | C6H10N4O2 | | MW: | 170.17 | | EINECS: | 226-621-9 | | Product Categories: | Nucleotides and Nucleosides;5-FOA;Bases & Related Reagents;Nucleotides;Building Blocks;C6 to C8;Chemical Synthesis;Heterocyclic Building Blocks;Pyrimidines | | Mol File: | 5440-00-6.mol |  |
| | 5,6-Diamino-1,3-dimethyluracil hydrate Chemical Properties |
| Melting point | 210-214 °C (dec.)(lit.) | | Boiling point | 243.6±50.0℃ (760 Torr) | | density | 1.350±0.06 g/cm3 (20 ºC 760 Torr) | | Fp | 101.1±30.1℃ | | storage temp. | 2-30°C | | solubility | DMSO, Methanol | | form | Solid | | pka | 4.42±0.70(Predicted) | | color | Pale Brown | | BRN | 157451 | | EPA Substance Registry System | 2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-1,3-dimethyl- (5440-00-6) |
| WGK Germany | 3 | | F | 10-34 | | TSCA | TSCA listed |
| | 5,6-Diamino-1,3-dimethyluracil hydrate Usage And Synthesis |
| Chemical Properties | Pale Brown Solid | | Uses | 5,6-Diamino-1,3-dimethyluracil hydrate can be used as reactant involved in the synthesis of biologically active molecules including: 1H-Imidazol-1-yl substituted 8-phenylxanthines for use as adenosine receptor ligands ; Pyrimidinyl purinediones via cyclocondensation ; Theophylline derivatives as adenosine receptor antagonists ; Pteridine analogs for use as monoamine oxidase B and nitric oxide synthase inhibitors ; Fused tricyclic xanthines and Cadmium uraciliminoethylpyridine complexes for use as antiproliferatives against C6 glioma cells6. | | Uses | 5,6-Diamino-1,3-dimethyl Uracil (cas# 5440-00-6) is a compound useful in organic synthesis. | | Uses | Reactant involved in the synthesis of biologically active molecules including:
- 1H-Imidazol-1-yl substituted 8-phenylxanthines for use as adenosine receptor ligands
- Pyrimidinyl purinediones via cyclocondensation
- Theophylline derivatives as adenosine receptor antagonists
- Pteridine analogs for use as monoamine oxidase B and nitric oxide synthase inhibitors
- Fused tricyclic xanthines
- Cadmium uraciliminoethylpyridine complexes for use as antiproliferatives against C6 glioma cells
| | Purification Methods | It recrystallises from EtOH. The hydrochloride has m 310o (from MeOH), and the perchlorate has m 246-248o. [UV: Bredereck et al. Chem Ber 92 583 1959, Taylor et al. J Am Chem Soc 77 2243 1955, Beilstein 25 III/IV 4133.] |
| | 5,6-Diamino-1,3-dimethyluracil hydrate Preparation Products And Raw materials |
| Raw materials | Cyanoacetic acid | | Preparation Products | ISOCAFFEINE-->8-(3-Pyridyl)theophyline-->2,4(1H,3H)-Pteridinedione, 1,3-dimethyl-7-phenyl--->4,6-Dimethyl-1H-1,2,3-triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione-->NSC14355 |
|